Danske Bank analysuppdatering Zenicor

Zenicor – UK Screening project order is the main attraction

Sales growth returned in Q1 and, although it was a touch below our estimate, we see several drivers for improved growth in coming quarters. The key news last week was Zenicor’s supplier agreement in the world’s largest stroke screening project – an important validation for the product, as the UK’s National Health service (NHS) is very influential in the European healthcare sphere.

Läs analysen här